Diaplatin – a new and powerful active pharmaceutical ingredient (API) against cancer

Kurzbeschreibung:
The new diaplatin complexes show activity against human cancer cell lines, thus proving their applicability in cancer therapy.

PDF-Dokument

Kontakt:
TransMIT GmbH
Kerkrader Str. 3
35394 Gießen
Telefon: +49 (6 41) 9 43 64 - 0
E-Mail: patente@transmit.de

Weiterempfehlen